ArticleCancers2024

Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.

Sara Mokbel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.